Data Foundry

Drug recalls 2018

Aripiprazole Tablets — Class II drug recall D-0595-2018

Terminated recall by AMERICAN HEALTH PACKAGING, reported 2018-02-21, distributed nationwide. CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specificati

Recall numberD-0595-2018
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAMERICAN HEALTH PACKAGING, Columbus, OH, United States
Recall initiated2018-01-19
Classified2018-03-13
Reported by FDA2018-02-21
Terminated2019-03-14
DistributedNationwide (US)
Quantity270 cartons
Reason classescgmp
NDC60687-0157, 60687-0157-11, 60687-0157-21, 60687-0157-94, 60687-0168, 60687-0168-01, 60687-0168-11, 60687-0168-65, 60687-0179, 60687-0179-01, 60687-0179-11, 60687-0179-65, 60687-0191, 60687-0191-11, 60687-0191-21, 60687-0191-94, 60687-0202, 60687-0202-11, 60687-0202-21, 60687-0202-94, 60687-0213, 60687-0213-11, 60687-0213-21, 60687-0213-94
Lot numbers174096
Expiration dates2019-05-31

Product

Aripiprazole Tablets, USP, 10 mg, 100 Tablets (10 x 10) unit dose blisters [NDC60687-179-11; UPC (01) 003 60687 179 11 7] per carton (NDC 60687-179-01), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.

Reason for recall

CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0595-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.